Could advances in personalized medicine and point-of-care device technology show promise in oncology? Learn more in this article from Future Science OA.
Boehringer Ingelheim has announced that the interchangeability study for their adalimumab biosimilar candidate has begun.
Researchers have discovered a new biomarker that could detect the risk of cardiovascular disease in asymptomatic patients with lupus.
Circulating eosinophils could potentially be utilized as biomarkers for chronic obstructive pulmonary disease.
Researchers have developed an innovative technique to detect tumor DNA in blood with a greater degree of sensitivity and precision.
Clinical trial results indicate that a new diagnostic patch could detect all severity levels of obstructive sleep apnea.
Researchers have developed a new test strip that could allow monitoring of heart failure at home.
Researchers from the University of Illinois (IL, USA) have developed a nanoporous sensor that could potentially predict the early stages of kidney failure.
Researchers from the Washington University School of Medicine (WA, USA) have identified a potential biomarker that could be utilized in predicting and monitoring the progression of glaucoma.
A blood test could predict how men diagnosed with advanced prostate cancer respond to targeted disease treatments.